Stroke prognosis in diabetes mellitus: New insights but questions remain

Expert Review of Cardiovascular Therapy

Volumn 7, Issue 10, 2009, Pages 1181-1185

  Arboix, Adrià ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; GLIBENCLAMIDE; GLIBORNURIDE; GLIMEPIRIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SULFONYLUREA; SULFONYLUREA RECEPTOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ALZHEIMER DISEASE; BLOOD CLOT LYSIS; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN HERNIA; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITIVE DEFECT; CONGESTIVE HEART FAILURE; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG TARGETING; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MORTALITY; NERVE DEGENERATION; NEUROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREVALENCE; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; STROKE; THROMBOEMBOLISM;

DIABETES COMPLICATIONS; HUMANS; PROGNOSIS; STROKE;

EID: 70449732279     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.98     Document Type: Editorial

References (50)

1. Mankovsky BN, Metzger BE, Molitch ME, Biller J. Cerebrovascular disorders in patients with diabetes mellitus. J. Diabetes Complicat. 10, 228-242 (1996). (Pubitemid 26270749)
2. Lukovits TG, Mazzone T, Gorelick PB. Diabetes mellitus and cerebrovascular disease. Neuroepidemiology 18, 1-14 (1999).
3. Alex M, Baron EK, Goldenberg S, Blumenthal HT. An autopsy study of cerebrovascular accident in diabetes mellitus. Circulation 25, 663-673 (1962).
4. Fisher CM. Lacunes: small, deep cerebral infarcts. Neurology 15, 774-784 (1965).
5. Norrving B, Staaf G. Pure motor stroke from presumed lacunar infarct. Incidence, risk factors and initial course. Cerebrovasc. Dis. 1, 203-209 (1991).
6. Arboix A, Martí-Vilalta JL. Lacunar stroke. Expert Rev. Neurother. 9(2), 179-196 (2009).
7. Mast H, Thompson JLP, Lee SH, Mohr JP, Sacco RL. Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. Stroke 26, 30-33 (1995).
8. Benavente O, White CL, Roldan AM. Small vessel strokes. Curr. Cardiol. Rep. 7, 23-28 (2005).
9. Arboix A, Font A, Garro C, Comes E, Massons J. Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients. J. Neurol. Neurosurg. Psychiatr. 78, 1392-1394 (2007). (Pubitemid 350221427)
10. Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 25,1977-1984 (1994).
11. Lithner F, Asplund K, Eriksson S, Hägg E, Strand T, Wester PO. Clinical characteristics in diabetic stroke patients. Particularités cliniques chez les diabétiques présentant un accident vasculaire cérébral. Diabetes Metab. 14, 15-19 (1988).
12. Arboix A, Rivas A, Garcia-Eroles L, De Marcos L, Massons J, Oliveres M. Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-hospital mortality. BMC Neurol. 5(1), 9 (2005). (Pubitemid 41418218)
13. Arboix A, Milian M, Oliveres M, Garcia-Eroles L, Massons J. Impact of female gender on prognosis in Type 2 diabetic patients with ischemic stroke. Eur. Neurol. 56, 6-12 (2006). (Pubitemid 44359536)
14. Megherbi SE, Milan C, Minier D et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke. Data from the European BIOMED Stroke Project. Stroke 34, 688-694 (2003). (Pubitemid 36307394)
15. Song E-C, Chu K, Jeong S-W et al. Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke 34, 2215-2220 (2003). (Pubitemid 37099839)
16. Arboix A, Oliveres M, Massons J, Targa C, García-Eroles L. Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care 23, 1527-1532 (2000). (Pubitemid 30746126)
17. Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke 35, 363-364 (2004).
18. Fuentes B, Castillo J, San José B et al. The prognostic value of capillary glucose levels in acute stroke. The GLycemia in Acute Stroke (GLIAS) Study. Stroke 40, 562-568 (2009).
19. Parsons MW, Barber PA, Desmond PM et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann. Neurol. 52, 20-28 (2002).
20. The European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischemic stroke and transient ischemic attack 2008. Cerebrovasc. Dis. 25, 457-507 (2008).
21. Wilcox R, Bousser MG, Betteridge DJ et al. Effects of pioglitazone in patients with Type 2 diabetes with or without previous stroke: results from Proactive (PRO-spective Pioglitazone Clinical Trial in Macrovascular Events 04). Stroke 38, 865-873 (2007). (Pubitemid 46568445)
22. Rubiera M, Ribó M, Delgado-Mederos R et al. Tandem internal carotid artery/ middle cerebral artery occlusion. An independent predictor of poor outcome after systemic thrombolysis. Stroke 37, 2301-2305 (2006). (Pubitemid 44337173)
23. Launer LJ. Diabetes: vascular or neurodegenerative. An epidemiological perspective. Stroke 40 (Suppl. 1), S53-S55 (2009).
24. Pasquier F, Boulogne A, Leys D, Fontaine P. Diabetes mellitus and dementia. Diabetes Metab. 32, 403-414 (2006).
25. Young SE, Mainous AG, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care 29, 2688-2693 (2006). (Pubitemid 44912200)
26. Biessels GJ, Stackcenborg S, Brunner E. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5, 64-74 (2006). (Pubitemid 41790697)
27. Qiu WQ, Folstein MF. Insulin, insulin-degrading enzyme an amyloid β peptide in Alzheimer's disease: review and hypothesis. Neurobiol. Aging 27, 190-198 (2006).
28. Yaffe K, Kanaya A, Lindquist K et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292, 2237-2242 (2004). (Pubitemid 39473161)
29. Kumari M, Brunner E, Fuhrer R. Minireview: mechanisms by which the metabolic syndrome and diabetes impair memory. J. Gerontol. A Biol. Sci. Med. Sci. 5, 228-232 (2000). (Pubitemid 30314068)
30. Gustafson D. Adiposity indices and dementia. Lancet Neurol. 5, 713-720 (2006).
31. Benoit SC, Clegg DJ, Seeley RJ et al. Insulin and leptin as adiposity signals. Recent Prog. Horm. Res. 59, 267-285 (2004).
32. Kwon HM, Kim BJ, Lee SH et al. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 37, 466-470 (2006).
33. Van der Flier WM, Barkhof F, Scheltens P. Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI. Ann. NY Acad. Sci. 1097, 215-224 (2007). (Pubitemid 47084890)
34. Henry-Feugeas MC. Alzheimer's disease in late-life dementia: A minor toxic consequence of devastating cerebrovascular dysfunction. Med. Hypotheses 70, 866-875 (2008).
35. De la Torre JC. Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol. Res. 26, 517-524 (2004).
36. Wardlaw JM, Sandercock PAG, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34, 806-812 (2003).
37. Lindley RI, Wang JJ, Wong M-Ch et al. Retinal microvascular changes in acute lacunar stroke. Lancet Neurol. 8, 628-634 (2009).
38. Arboix A. Retinal microvasculature in acute lacunar stroke. Lancet Neurol. 8, 596-598 (2009).
39. Zhu CZ, Auer RN. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J. Neurosurg. 101, 664-668 (2004).
40. Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 6, 258-268 (2007). (Pubitemid 46228081)
41. Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke 40, 604-609 (2009).
42. Simard JM, Chen M, Tarasov KV et al. Newly expressed SURI-regulated NC(Ca- ATP) channel mediates cerebral edema after ischemic stroke. Nat. Med. 12, 433-440 (2006).
43. Stumvoll M, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333-1346 (2005). (Pubitemid 40501297)
44. Arboix A. Potential impact of sulfonylureas in the outcome of Type 2 diabetic patients with ischemic stroke. Stroke 38, 2413-2414 (2007). (Pubitemid 47329615)
45. Kinte H, Schmidt S, Eliasziw M et al. Sulfonylureas improve outcome in patients with Type 2 diabetes and acute ischemic stroke. Stroke 38, 2526-2530 (2007). (Pubitemid 47329632)
46. Shook SJ, Gupta R, Vora NA, Tievsky AL, Katzan I, Krieger DW. Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke. J. Neuroimaging 16, 341-346 (2006). (Pubitemid 44521385)
47. Streifler JY. Editorial comment: statins, stroke outcome, and stroke prevention: when should we start treatment? Stroke 35, 1121 (2004).
48. Arboix A, Cabeza N, Garcia-Eroles L et al. Relevance of transient ischemic attack to early neurological recovery after nonlacunar ischemic stroke. Cerebrovasc. Dis. 18, 304-311 (2004). (Pubitemid 39664254)
49. Glazier SS, O'Rourke DM, Graham DI, Welsh FA. Induction of ischemic tolerance following brief local focal ischemic in rat brain. J. Cereb. Blood Flow Metab. 14, 545-553 (1994).
50. Ovbiagele B, Saver JL. Intensive statin therapy after stroke or transient ischemic attack. A sparcling success? Stroke 38, 1110-1112 (2007). (Pubitemid 46568486)